Loading clinical trials...
Loading clinical trials...
This study is carried out in patients with IBD and healthy subjects requiring ileocolonoscopy as part of routine care (disease monitoring or polyp/colon cancer screening). It aims the generation and culturing of organoids from digestive biopsies recovered from healthy and/or pathological (inflammatory) ileal and/or colonic mucosa during an ileo-colonoscopy. These cultures will make it possible to validate the organoid production method used in the context of the research (primary objective). In a second phase (secondary objectives), the study will aim to setup a screening tool by irradiating the organoids (step one) and then evaluate in vitro the regenerative activity of treatments dedicated to improve inflammatory bowel diseases and acute radiation enteritis (step two).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Groupe Hospitalier Ambroise Paré Hartmann
Neuilly-sur-Seine, Hauts-de-Seine, France
Start Date
September 19, 2022
Primary Completion Date
December 11, 2024
Completion Date
December 11, 2024
Last Updated
September 18, 2025
16
ACTUAL participants
biopsy
OTHER
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06579443